Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

1. An improved novel plasmid backbone, pTrial10, has been developed. We have used this vector to deliver the cDNA for the cystic fibrosis transmembrane conductance regulator (CFTR) to cells, both in vitro and in vivo, complexed with cationic liposomes. 2. Human 293 kidney epithelial cells (HEK 293) showed expression of an immunoprecipitable 165 kDa protein corresponding to CFTR when transfected in vitro with pTrial10-CFTR2, but not when the vector pTrial10 was used. 3. HEK 293 cells transfected with pTrial10-CFTR2, but not pTrial10, demonstrated a cAMP-dependent anion conductance, measured by fluorescence microscopy using a halide-sensitive probe, SPQ. 4. The CFTR-dependent, cAMP-sensitive chloride secretory response in murine tracheal epithelium could be measured if the calcium-dependent chloride secretory process was first maximally stimulated with a mixture of the Ca(2+)-ATPase inhibitor, TBHQ, and the calcium ionophore, A23187. With these conditions wild-type and CF-null (transgenic animals in which the cystic fibrosis (CF) gene has been disrupted so that no CFTR is produced) murine tracheas could be distinguished. The difference between the current elicited by forskolin in wild-type and CF tracheas was highly significantly different (P < 0.001), giving a CFTR-dependent current of 11.2 microA cm-2. 5. Transfection of the airways with pTrial10-CFTR2, but not pTrial10, significantly (P < 0.01) increased the CFTR-dependent chloride secretory current in CF tracheas. The degree of correction was greater when intra-tracheal installation rather than nasal insufflation was used to deliver the plasmids.

Original publication

DOI

10.1113/jphysiol.1997.sp021960

Type

Journal article

Journal

J Physiol

Publication Date

15/03/1997

Volume

499 ( Pt 3)

Pages

677 - 687

Keywords

4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid, Amiloride, Animals, Antioxidants, Avian Sarcoma Viruses, Calcimycin, Chloride Channels, Chlorides, Cyclic AMP, Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Diuretics, Genetic Therapy, HeLa Cells, Humans, Hydroquinones, Ionophores, Mice, Mice, Inbred CFTR, Molecular Sequence Data, Plasmids, Promoter Regions, Genetic, Trachea, Transfection